Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 10, 2015
[Prognostic evaluation of comorbidities in patients with myelodysplastic syndrome]Yi Li, Tiejun Qin, Zefeng Xu, et al.
Hematology (Amsterdam, Netherlands)|April 10, 2024
Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with <i>DDX41</i> mutationsXin Wang, Zhijian Xiao, Tiejun Qin, et al.
Hematological Oncology|May 24, 2022
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot studyShiqiang Qu, Zefeng Xu, Tiejun Qin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia]Tiejun Qin, Zefeng Xu, Yue Zhang, et al.
Blood Science (Baltimore, Md.)|November 9, 2023
Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteinsHuijun Huang, Jinqin Liu, Lin Yang, et al.
Hematological Oncology|June 18, 2026
Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 MutationLinlin Liu, Bing Li, Tiejun Qin, et al.
Pathology, Research and Practice|April 1, 2025
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasmsFuhui Li, Yudi Zhang, Chengwen Li, et al.
British Journal of Haematology|April 24, 2024
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31Linlin Liu, Bing Li, Zefeng Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 16, 2016
[The assessment of symptomatic burden among Ph/BCR- ABL negative myeloproliferative neoplasm patients]Junqing Xu, Zefeng Xu, Jingya Wang, et al.
Leukemia Research|September 4, 2014
Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosisJingya Wang, Junqing Xu, Robert Peter Gale, et al.
Pageof 5